Anzahl der Publikationen: 9
Zeitschriftenartikel
Carlet, Michela; Schmelz, Karin; Vergalli, Jenny; Herold, Tobias; Senft, Daniela; Jurinovic, Vindi; Hoffmann, Thomas; Proba, Jutta; Weichert, Nina; Junghanss, Christian; Roth, Mareike; Eschenburg, Georg; Barz, Malwine; Henze, Guenter; Eckert, Cornelia; Eggert, Angelika; Zuber, Johannes; Hundsdoerfer, Patrick und Jeremias, Irmela
(2022):
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL.
In: EMBO Molecular Medicine, Bd. 15, Nr. 1, e14557
Lenk, Lennart; Carlet, Michela; Vogiatzi, Fotini; Spory, Lea; Winterberg, Dorothee; Cousins, Antony; Vossen-Gajcy, Michaela; Ibruli, Olta; Vokuhl, Christian; Cario, Gunnar; El Ayoubi, Omar; Kramer, Lisa; Ritgen, Matthias; Bruggemann, Monika; Hasler, Robert; Schrappe, Martin; Fuhrmann, Stephan; Halsey, Christina; Jeremias, Irmela; Hobeika, Elias; Jumaa, Hassan; Alsadeq, Ameera und Schewe, Denis M.
(2021):
CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia.
In: Communications Biology, Bd. 4, Nr. 1, 73
Sanchez-Martinez, Diego; Gutierrez-Aguera, Francisco; Romecin, Paola; Vinyoles, Meritxell; Palomo, Marta; Tirado, Nestor; Romina Zanetti, Samanta; Juan, Manel; Carlet, Michela; Jeremias, Irmela und Menendez, Pablo
(2021):
Enforced sialyl-Lewis-X (sLeX) display in E-selectin ligands by exofucosylation is dispensable for CD19-CAR T-cell activity and bone marrow homing.
In: Clinical and Translational Medicine, Bd. 11, Nr. 2, e280
Jensen, Patrizia; Carlet, Michela; Schlenk, Richard F.; Weber, Andrea; Kress, Jana; Brunner, Ines; Slabicki, Mikolaj; Grill, Gregor; Weisemann, Simon; Cheng, Ya-Yun; Jeremias, Irmela; Scholl, Claudia und Froehling, Stefan
(2020):
Requirement for LIM kinases in acute myeloid leukemia.
In: Leukemia, Bd. 34, Nr. 12: S. 3173-3185
Liu, Wen-Hsin; Mrozek-Gorska, Paulina; Wirth, Anna-Katharina; Herold, Tobias; Schwarzkopf, Larissa; Pich, Dagmar; Voelse, Kerstin; Melo-Narvaez, M. Camila; Carlet, Michela; Hammerschmidt, Wolfgang und Jeremias, Irmela
(2020):
Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL.
In: Biomarker Research, Bd. 8, Nr. 1, 46
Stief, Sophie M.; Hanneforth, Anna-Li; Weser, Sabrina; Mattes, Raphael; Carlet, Michela; Liu, Wen-Hsin; Bartoschek, Michael D.; Moreno, Helena Dominguez; Oettle, Matthias; Kempf, Julia; Vick, Binje; Ksienzyk, Bianka; Tizazu, Belay; Rothenberg-Thurley, Maja; Quentmeier, Hilmar; Hiddemann, Wolfgang; Vosberg, Sebastian; Greif, Philipp A.; Metzeler, Klaus H.; Schotta, Gunnar; Bultmann, Sebastian; Jeremias, Irmela; Leonhardt, Heinrich und Spiekermann, Karsten
(2020):
Loss of KDM6A confers drug resistance in acute myeloid leukemia.
In: Leukemia, Bd. 34, Nr. 1: S. 50-62
Finkenzeller, Cornelia; Carlet, Michela; Vosberg, Sebastian; Neumann, Martin; Riecken, Kristoffer; Cornils, Kerstin; Fehse, Boris; Baldus, Claudia D.; Greif, Philipp A. und Jeremias, Irmela
(2017):
Clones with and without Sensitivity towards Treatment in Vivo Co-Exist within a Single Sample of a Patient with ALL.
In: Annals of Hematology, Bd. 96:
S75-S75
Vick, Binje; Rothenberg, Maja; Sandhöfer, Nadine; Carlet, Michela; Finkenzeller, Cornelia; Krupka, Christina; Grunert, Michaela; Trumpp, Andreas; Corbacioglu, Selim; Ebinger, Martin; André, Maya C.; Hiddemann, Wolfgang; Schneider, Stephanie; Subklewe, Marion; Metzeler, Klaus H.; Spiekermann, Karsten und Jeremias, Irmela
(2015):
An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging.
In: PLOS ONE
10(3), e0120925
[PDF, 3MB]
Diese Liste wurde am
Sat Dec 21 18:08:35 2024 CET
erstellt.